Skip to Main Content

Paper Details

Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.
Transplant Cell Ther
2
2023
-, B cell acute lymphoblastic leukemia, B-ALL, CAR, CAR T cell construct, CART, CART constructs, CART-A, CART-A antigen, CART-B, CD19, CD22, Chimeric Antigen, Chimeric Antigen Receptor T Cell Failure, Chimeric Antigen Receptor T Cells, Patients, children, chimeric, chimeric antigen receptor, chimeric antigen receptor (CAR) T cell, patients
Author NameAffiliation
Seth M SteinbergNational Cancer Institute, National Institutes of Health
Seth M SteinbergNational Cancer Institute, National Institutes of Health
David F StroncekCenter for Cellular Engineering, National Institutes of Health Clinical Center
David F StroncekCenter for Cellular Engineering, National Institutes of Health Clinical Center
  • 1 - 4

Datasets

Release 1.2